ZYVOX May Lead to Shorter Hospital Stays
TORONTO - Data recently presented during the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Toronto, Canada show that ZYVOX (linezolid injection, tablets and for oral suspension) may help some patients with certain difficult-to-treat infections be discharged from hospitals sooner. ZYVOX, according to its manufacturer Pharmacia, is associated with a significantly higher rate of hospital discharge in the first week of therapy among patients with complicated skin and soft tissue infections. For more information visit www.pharmacia.com.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
